Eli Lilly develops and sells pharmaceuticals, including treatments for diabetes and cancer.
Oral Wegovy at $150/month is driving record adoption (300k new scripts/week vs 200k), proving massive price elasticity and consumer demand for preventive metabolic medicine; Lilly Direct digital channel now captures >50% of new patients, bypassing traditional sales model.